New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
October 31, 2019 17:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel,...
NATIONAL KIDNEY FOUNDATION AND LOGISTICARE/CIRCULATION JOIN FORCES TO AID KIDNEY PATIENTS
October 10, 2019 10:00 ET | LogistiCare
Atlanta, Oct. 10, 2019 (GLOBE NEWSWIRE) -- The National Kidney Foundation (NKF) Serving New England and LogistiCare/Circulation invite you to take part in the 2019 Boston Walk on October 13, at...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
September 23, 2019 16:20 ET | Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
August 07, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Presents Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting
July 08, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, July 08, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
May 30, 2019 08:05 ET | Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...
RND logo.PNG
Kidney Function Test Market To Reach USD 1061.0 Million By 2026 | Reports And Data
May 28, 2019 12:45 ET | Reports And Data
The alerting rise in aging and geriatric population which leads to the high prevalence of kidney diseases, obesity and cardiovascular diseases has been driving the market into growth. The increase in...
LogistiCare and National Kidney Foundation Partner to Conquer Kidney Disease
May 20, 2019 16:00 ET | LogistiCare
Atlanta, May 20, 2019 (GLOBE NEWSWIRE) -- The National Kidney Foundation of Georgia hosted the 2019 Atlanta Kidney Walk on Saturday, May 18 at Atlantic Station in Midtown Atlanta. Attendees with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2019 Financial Results
May 08, 2019 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Review of Potential Strategic Transactions
April 15, 2019 16:30 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...